Patient-reported outcomes of 905 patients with breast cancer two years after start of curative systemic treatment. 7. Juni 2016 Marschner, N., Trarbach, T., Dörfel, S., Meyer, D., Müller-Hagen, S., Zaiss, M., Boller, E., Kruggel, L., 2016. Oncol Res Treat 39 (suppl 5)(V385), 116. doi:10.1159/000449050 Abstract Overall survival of 4865 patients with metastatic solid tumours treated in German routine practice – combined results from four prospective, multicentre cohort studies. Marschner, N., Potthoff, K., Schnell, R., Tesch, H., Zahn, M.-O., Hegewisch-Becker, S., Jänicke, M., 2016. Oncol Res Treat 39 (suppl.3)(V174), 43. doi:10.1159/000449050… Weiterlesen Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with lung cancer: results from an interim analysis of the non-interventional study NADIR. Potthoff, K., Lück, A., Frost, N., Losem, C., Weide, R., Schulz, H., 2016. Oncol Res Treat 39 (suppl3)(P949), 292. doi:10.1159/000449050… Weiterlesen